Sakar Healthcare Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 21.95 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 107.26 Cr
- Satisfied Charges ₹ 16.90 Cr
- Revenue Growth 5.86%
- Profit Growth -16.30%
- Ebitda 12.72%
- Net Worth 35.99%
- Total Assets 25.60%
About Sakar Healthcare
Sakar Healthcare Limited (SHL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 March 2004 and has a history of 20 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
It is listed on the National Stock Exchange(NSE) under the ticker symbol SAKAR.
The Corporate was formerly known as Sakar Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 21.95 Cr.
The company currently has active open charges totaling ₹107.26 Cr. The company has closed loans amounting to ₹16.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sakar Healthcare Limited India are Dharmesh Thaker as CFO and Bharat Soni as Company Secretary. Hemendrakumar Shah, Jignesh Parikh, Sanjay Shah, and Seven other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24231GJ2004PLC043861
- Company No.
043861
- Stock Symbol
NSE : SAKAR
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2004
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
What products or services does Sakar Healthcare Limited offer?
Sakar Healthcare Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Aceclofenac Tablet, Aceclofenac Injection.
Who are the key members and board of directors at Sakar Healthcare?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Shah  | Managing Director | 26-Mar-2004 | Current |
| Aarsh Shah | Managing Director | 01-Jun-2012 | Current |
| Dharmesh Thaker | CFO | 31-Oct-2021 | Current |
| Bharat Soni | Company Secretary | 29-Oct-2020 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Srivastav | Director | 01-Apr-2015 | Current |
| Hemendrakumar Shah | Director | 28-Sep-2020 | Current |
| Jignesh Parikh | Director | 06-Nov-2023 | Current |
| Shailesh Patel | Director | 01-Apr-2015 | Current |
| Visalakshi Chandramouli | Director | 01-Sep-2023 | Current |
| Sunil Marathe | Whole-Time Director | 06-Nov-2023 | Current |
Financial Performance of Sakar Healthcare.
Sakar Healthcare Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.86% increase. The company also saw a substantial fall in profitability, with a 16.3% decrease in profit. The company's net worth Soared by an impressive increase of 35.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sakar Healthcare?
In 2024, Sakar Healthcare had a promoter holding of 53.15% and a public holding of 46.85%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saanvi Advisors LimitedKhyati Shah is a mutual person
Sakar Oncology Private LimitedSanjay Shah and Aarsh Shah are mutual person
Prism Finance LimitedHemendrakumar Shah is a mutual person
Linux Laboratories Private LimitedVisalakshi Chandramouli is a mutual person
Anderson Diagnostic Services Private LimitedVisalakshi Chandramouli is a mutual person
Bisil Plast LimitedKhyati Shah is a mutual person
Charges (Loans)
₹107.26 Cr
₹16.90 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 107.26 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2006 | State Bank Of India | ₹107.26 Cr | Open |
| 24 Aug 2021 | Others | ₹10.00 Cr | Satisfied |
| 14 Aug 2020 | Others | ₹9.00 M | Satisfied |
| 13 Sep 2019 | Others | ₹5.00 Cr | Satisfied |
| 09 Dec 2004 | The United Western Bank Limited "Hitek"; Opp. | - | Satisfied |
How Many Employees Work at Sakar Healthcare?
Sakar Healthcare has a workforce of 52 employees as of Jan 15, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sakar Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sakar Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
